Paper41253147
Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche.
Aprile A and 2 others. Cell Rep Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche. Papers, record 41253147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41253147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Therapy | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Hemoglobinopathies | Major topic |
| Bone Marrow | Major topic |
| Stem Cell Niche | Major topic |
| Humans | |
| Gene Editing | |
| Clinical Trials as Topic | |
| Animals | |
| Anemia, Sickle Cell |
Source PubMed
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18245381 | Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18245381 | PubMed |
| 2 | 33283989 | CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33283989 | PubMed |
| 3 | 37646679 | CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37646679 | PubMed |
| 4 | 40592819 | Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia. | Nat Commun | 2025 | https://conductscience.org/library/papers/40592819 | PubMed |
| 5 | 32396618 | Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease. | Blood Adv | 2020 | https://conductscience.org/library/papers/32396618 | PubMed |
| 6 | 35073399 | Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans. | Blood | 2022 | https://conductscience.org/library/papers/35073399 | PubMed |
| 7 | 36161320 | Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study. | Am J Hematol | 2023 | https://conductscience.org/library/papers/36161320 | PubMed |
| 8 | 14574413 | Osteoblastic cells regulate the haematopoietic stem cell niche. | Nature | 2003 | https://conductscience.org/library/papers/14574413 | PubMed |
| 9 | 19056937 | Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. | Science | 2008 | https://conductscience.org/library/papers/19056937 | PubMed |
| 10 | 35858618 | Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. | Cell Stem Cell | 2022 | https://conductscience.org/library/papers/35858618 | PubMed |
| 11 | 39293082 | UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease. | Blood Adv | 2024 | https://conductscience.org/library/papers/39293082 | PubMed |
| 12 | 25957113 | Microarchitectural and mechanical characterization of the sickle bone. | J Mech Behav Biomed Mater | 2015 | https://conductscience.org/library/papers/25957113 | PubMed |
| 13 | 19474450 | A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction. | Blood | 2009 | https://conductscience.org/library/papers/19474450 | PubMed |
| 14 | 28830890 | Increased risk of leukemia among sickle cell disease patients in California. | Blood | 2017 | https://conductscience.org/library/papers/28830890 | PubMed |
| 15 | 33956057 | Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. | Blood Adv | 2021 | https://conductscience.org/library/papers/33956057 | PubMed |
| 16 | 12639987 | Spontaneous circulation of myeloid-lymphoid-initiating cells and SCID-repopulating cells in sickle cell crisis. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12639987 | PubMed |
| 17 | 36333351 | Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. | Nat Commun | 2022 | https://conductscience.org/library/papers/36333351 | PubMed |
| 18 | 31279229 | In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods. | Mol Ther Nucleic Acids | 2019 | https://conductscience.org/library/papers/31279229 | PubMed |
| 19 | 9734950 | Granulocytosis causing sickle-cell crisis. | Lancet | 1998 | https://conductscience.org/library/papers/9734950 | PubMed |
| 20 | 40419809 | Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial. | Nat Med | 2025 | https://conductscience.org/library/papers/40419809 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42074029 | Clinical Trial Landscape of Gene-Edited Autologous Hematopoietic Stem Cells for Hemoglobinopathies and Immunodeficiencies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074029 | PubMed |
| 41753067 | Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation. | J Clin Med | 2026 | https://conductscience.org/library/papers/41753067 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41253147
GET https://conductscience.org/api/papers/v1/41253147/references?page=2